2019-2023 Competing in the CA 19-9 Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

2019-2023 Competing in the CA 19-9 Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

  • March 2019 •
  • Report ID: 5760521 •
  • Format: PDF
2019-2023 Competing in the CA 19-9 Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

This new report provides analysis of CA 19-9 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Market Segmentation

Centralized Testing

- Hospitals
- Commercial/Private Laboratories

POC/Decentralized Testing

- Physician Offices/Group Practices
- Cancer Clinics

List of Tables

List of Tables


France: CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment